The Valley Desk

NCT00448539 · Interventional trial

Open-Label Extension Study of Rufinamide Given as Adjunctive Therapy in Patients With Refractory Partial Seizures

Overall registry status Terminated

Phase 3

Conditions Refractory Partial Onset Seizures

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov